UCSD Profiles

Dr. Le is Professor of Clinical Pharmacy at the UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences. Her academic career spans more than 24 years and is distinguished by over 200+ peer-reviewed publications focused on patient-oriented research in clinical pharmacology, including model-informed precision dosing (MIPD), antimicrobial stewardship, resistant infections, medication safety, and national vancomycin and extracorporeal membrane oxygenation (ECMO) guidelines. She has delivered more than 100+ invited lectures nationally and internationally and has served as a preceptor and mentor to over 300 students (including Fulbright scholars), residents, fellows, and early-career faculty.

Dr. Le’s scholarship and professional leadership extend globally, with sustained contributions to medication safety and antimicrobial optimization throughout Asia (including Vietnam, Singapore, Thailand, China) and Jordan. Her work has supported the development and implementation of evidence based dosing strategies, therapeutic drug monitoring programs, and systems level medication safety initiatives in diverse healthcare settings, spanning academic medical centers, national hospitals, and resource limited environments. Notably, her efforts include advancing global standards for safe and effective antimicrobial use and fostering international collaborations to address antimicrobial resistance and prevent medication-related harm across the lifespan, from infants to geriatrics.

She served on study sections for the National Institutes of Health (NIH), the Agency for Healthcare Research and Quality (AHRQ), the Patient Centered Outcomes Research Institute (PCORI), the National Science Foundation (NSF), and the American Institute of Biological Sciences (AIBS). Her investigator-initiated research in pediatric clinical pharmacology, antimicrobial stewardship, and medication safety has been supported by more than $11.8 million in competitive funding from the NIH, private and philanthropic foundations. In addition, Dr. Le has served as an advisory board member to the U.S. Food and Drug Administration (FDA) since 2018, contributing expertise in medication safety, pharmacotherapy, infectious diseases, and regulatory science.

Based on Dr. Le’s extensive expertise, global experience, and board certification in pharmacotherapy with added qualification in infectious diseases, she is exceptionally well positioned to lead multidisciplinary teams of U.S. and international experts to accelerate innovation in medication safety, including infusion and specialty pharmacy services that integrate with home health and ambulatory care models. Her depth of knowledge extends across these domains, including more than 20 years of patient care education and implementation science in model-informed precision dosing, which supported the first vancomycin assay and therapeutic drug monitoring program in Vietnam and informed broader medication safety practices across Asia.